Heavy/light chain ratios may be a prognostic marker for myeloma patients
The results of a small Spanish study indicate that heavy/light chain ratios may be a prognostic marker for myeloma patients.
Japanese researchers recently found that high levels of the proteins survivin and aurora-B may be associated with disease progression in myelodysplastic syndromes.